SCMS Monthly Performance Report

The project, which began in October 2005, has delivered $1,171 million in products to clients across 54 countries, with 11,970 deliveries made. The majority of antiretroviral therapy (ARV) deliveries, 99 percent by volume and value, were generics. The project has also made notable progress in technical assistance, with 35 countries receiving support in areas such as quantification, warehousing, and distribution. A total of 748 technical assistance assignments have been completed, and three state-of-the-art regional distribution centers (RDCs) are operational in Ghana, Kenya, and South Africa. Notably, no counterfeit products have been detected in the SCMS global supply chain. One of the project's key highlights was the official opening and handover of the warehouse-in-a-box (WIB) facility in Keko, Tanzania. This facility, which spans 4,282 square meters, will expand storage space and replace currently rented warehouse facilities, saving government funds. The WIBs feature modern technology, and SCMS has been training MSD staff in warehouse management to ensure optimal use of the new facilities. The project has also continued to develop the Capability Maturity Model and Key Performance Indicator diagnostic tools, with input from partner organization experts. These tools were piloted in South Africa's Gauteng province, Botswana, and Paraguay, providing valuable feedback that will be incorporated into the next version of the CMM. In the Global Supply Chain pillar, the project delivered $81 million worth of commodities via 640 shipments to clients, with 81 percent of deliveries made within 14 days of the promised delivery date. Client on-time delivery was supported by improvements in vendor performance, with 87 percent of vendor deliveries on target during the quarter. The project also made significant progress in the Health Systems Strengthening pillar, including the first SCMS male circumcision meeting in South Africa, which informed field offices and USAID activity managers about commodity specifications, logistical needs, and lessons learned. In addition, the project conducted a re-audit of an MC kit supplier in South Africa, which highlighted issues with lot numbers and sterilization cycles. The manufacturer is correcting these issues, and the firm was re-approved as a supplier for SCMS. The project also conducted re-audits of three international pharmaceutical wholesalers in Europe, with one supplier receiving Grade A status and another making significant modifications to its supplier prequalification program and quality system.